Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 AUD | -3.85% | -3.85% | -26.47% |
Apr. 08 | Starpharma, Medicxi Co-Found Petalion Therapeutics; Shares Surge 16% | MT |
Mar. 18 | Starpharma Holdings Limited(ASX:SPL) dropped from S&P/ASX Emerging Companies Index | CI |
Sales 2022 | 5.16M 3.33M | Sales 2023 | 4.21M 2.72M | Capitalization | 127M 82.14M |
---|---|---|---|---|---|
Net income 2022 | -16M -10.33M | Net income 2023 | -15M -9.68M | EV / Sales 2022 | 50.5 x |
Net cash position 2022 | 41.73M 26.93M | Net cash position 2023 | 26.91M 17.37M | EV / Sales 2023 | 23.8 x |
P/E ratio 2022 |
-18.5
x | P/E ratio 2023 |
-7.75
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 92.68% |
1 day | -3.85% | ||
1 week | -7.41% | ||
1 month | -3.85% | ||
3 months | -10.71% | ||
6 months | -7.41% | ||
Current year | -26.47% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | Jan. 07 |
Justin Cahill
DFI | Director of Finance/CFO | - | 23-04-02 |
Tony Eglezos
PRN | Corporate Officer/Principal | - | 13-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Davies
BRD | Director/Board Member | - | 22-03-31 |
Robert Thomas
CHM | Chairman | 79 | 13-12-03 |
David McIntyre
BRD | Director/Board Member | 53 | 20-02-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.125 | -3.85% | 279 417 |
24-04-22 | 0.13 | 0.00% | 547,549 |
24-04-19 | 0.13 | +4.00% | 313,928 |
24-04-18 | 0.125 | -3.85% | 418,609 |
24-04-17 | 0.13 | -3.70% | 119,845 |
Delayed Quote Australian S.E., April 23, 2024 at 02:10 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.47% | 34.48M | |
+25.46% | 659B | |
+26.87% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.38% | 215B | |
+6.62% | 210B | |
-6.09% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- SPL Stock